Literature DB >> 11701632

Trinucleotide repeats: mechanisms and pathophysiology.

C J Cummings1, H Y Zoghbi.   

Abstract

Within the closing decade of the twentieth century, 14 neurological disorders were shown to result from the expansion of unstable trinucleotide repeats, establishing this once unique mutational mechanism as the basis of an expanding class of diseases. Trinucleotide repeat diseases can be categorized into two subclasses based on the location of the trinucleotide repeats: diseases involving noncoding repeats (untranslated sequences) and diseases involving repeats within coding sequences (exonic). The large body of knowledge accumulating in this fast moving field has provided exciting clues and inspired many unresolved questions about the pathogenesis of diseases caused by expanded trinucleotide repeats. This review summarizes the current understanding of the molecular pathology of each of these diseases, starting with a clinical picture followed by a focused description of the disease genes, the proteins involved, and the studies that have lent insight into their pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11701632     DOI: 10.1146/annurev.genom.1.1.281

Source DB:  PubMed          Journal:  Annu Rev Genomics Hum Genet        ISSN: 1527-8204            Impact factor:   8.929


  86 in total

Review 1.  Neurodegeneration: what is it and where are we?

Authors:  Serge Przedborski; Miquel Vila; Vernice Jackson-Lewis
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  Intracellular transcription of G-rich DNAs induces formation of G-loops, novel structures containing G4 DNA.

Authors:  Michelle L Duquette; Priya Handa; Jack A Vincent; Andrew F Taylor; Nancy Maizels
Journal:  Genes Dev       Date:  2004-07-01       Impact factor: 11.361

3.  Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia.

Authors:  Cristy Tower; Lianwu Fu; Rachel Gill; Mark Prichard; Mathieu Lesort; Elizabeth Sztul
Journal:  Neurobiol Dis       Date:  2010-08-20       Impact factor: 5.996

4.  Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain.

Authors:  Yuxin Mao; Francesca Senic-Matuglia; Pier Paolo Di Fiore; Simona Polo; Michael E Hodsdon; Pietro De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-23       Impact factor: 11.205

5.  OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells.

Authors:  Irina V Kovtun; Yuan Liu; Magnar Bjoras; Arne Klungland; Samuel H Wilson; Cynthia T McMurray
Journal:  Nature       Date:  2007-04-22       Impact factor: 49.962

6.  An unusually low microsatellite mutation rate in Dictyostelium discoideum, an organism with unusually abundant microsatellites.

Authors:  Ryan McConnell; Sara Middlemist; Clea Scala; Joan E Strassmann; David C Queller
Journal:  Genetics       Date:  2007-10-18       Impact factor: 4.562

7.  Genome-wide prediction of G4 DNA as regulatory motifs: role in Escherichia coli global regulation.

Authors:  Pooja Rawal; Veera Bhadra Rao Kummarasetti; Jinoy Ravindran; Nirmal Kumar; Kangkan Halder; Rakesh Sharma; Mitali Mukerji; Swapan Kumar Das; Shantanu Chowdhury
Journal:  Genome Res       Date:  2006-05       Impact factor: 9.043

8.  Investigating the binding mode of an inhibitor of the MBNL1·RNA complex in myotonic dystrophy type 1 (DM1) leads to the unexpected discovery of a DNA-selective binder.

Authors:  Chun-Ho Wong; Stacie L Richardson; Yen-Jun Ho; Alex M H Lucas; Tiziano Tuccinardi; Anne M Baranger; Steven C Zimmerman
Journal:  Chembiochem       Date:  2012-10-24       Impact factor: 3.164

9.  Impact of bulge loop size on DNA triplet repeat domains: Implications for DNA repair and expansion.

Authors:  Jens Völker; G Eric Plum; Vera Gindikin; Horst H Klump; Kenneth J Breslauer
Journal:  Biopolymers       Date:  2014-01       Impact factor: 2.505

Review 10.  Genetic determinants of cardiac hypertrophy.

Authors:  Ali J Marian
Journal:  Curr Opin Cardiol       Date:  2008-05       Impact factor: 2.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.